DARE BIOSCIENCE INC (DARE) Stock Earnings & Estimates
USA - NASDAQ:DARE - US23666P2002 - Common Stock
2.18 USD
+0.03 (+1.4%)
2.1503 USD
-0.03 (-1.36%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10M | 2.808M -71.92% | 9.8K -99.65% | 681.36K 6,852.65% | 34.221M 4,922.46% | 66.522M 94.39% | 166.79M 150.73% | 280.07M 67.92% | 419.33M 49.72% | 551.98M 31.63% | 679.54M 23.11% | |
| EBITDA YoY % growth | -31.37M 19.65% | -30.902M 1.49% | -23.409M 24.25% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.39M 19.66% | -30.94M 1.43% | -23.452M 24.20% | -19.601M 16.42% | -19.556M 0.23% | 28.269M 244.55% | 119.71M 323.47% | 216.75M 81.06% | 330.33M 52.40% | 457.8M 38.59% | 569.32M 24.36% | |
| Operating Margin | -313.90% | -1,101.89% | -239,301.02% | -2,876.72% | -57.15% | 42.50% | 71.77% | 77.39% | 78.78% | 82.94% | 83.78% | |
| EPS YoY % growth | -4.44 47.89% | -4.08 8.11% | -0.52 87.25% | -1.58 -204.04% | 0.26 116.13% | 2.05 704.00% | 4.04 97.01% | 6.49 60.61% | 10.35 59.51% | 14.34 38.59% | 17.80 24.11% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 33.85% | -0.36 45.08% | -0.15 69.40% | -0.16 63.73% | 0.02 105.61% | -0.47 -31.43% | 0.12 180.00% | 0.13 181.25% | 0.14 600.00% | 0.15 132.61% |
| Revenue Q2Q % growth | 13.26K | 645.997K 1,109.37% | 3.774M 14,740.74% | 4.896M 23,414.29% | N/A | N/A | 10.009M 165.21% | 10.444M 113.32% | 11.315M | 11.749M |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.134M -9.67% | -5.739M -6.52% | -6.884M -50.27% | -7.184M -37.98% | -8.621M -67.92% | -8.953M -55.99% | 1.507M 121.89% | 1.572M 121.88% | 1.703M 119.75% | 1.769M 119.76% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.45 -129.61% | -0.59 | 0.14 | 23.94% |
| Q1 2025 Q2Q % growth | -0.50 40.48% | -0.59 | 0.09 | 15.48% |
| Q4 2024 Q2Q % growth | -0.65 9.72% | -0.54 | -0.11 | -19.49% |
| Q3 2024 Q2Q % growth | -0.55 49.07% | -0.75 | 0.20 | 26.47% |
| Q2 2024 Q2Q % growth | 1.52 226.67% | 0.00 | 1.52 | % |
| Q1 2024 Q2Q % growth | -0.84 22.22% | -0.73 | -0.11 | -14.38% |
| Q4 2023 Q2Q % growth | -0.72 68.42% | -1.20 | 0.48 | 39.98% |
| Q3 2023 Q2Q % growth | -1.08 -12.50% | -1.20 | 0.12 | 9.96% |
| Q2 2023 Q2Q % growth | -1.20 | -1.20 | 0.00 | 0.30% |
| Q1 2023 Q2Q % growth | -1.08 10.00% | -1.22 | 0.14 | 11.76% |
| Q4 2022 Q2Q % growth | -2.28 -5.56% | -1.67 | -0.61 | -36.30% |
| Q3 2022 Q2Q % growth | -0.96 55.56% | -1.44 | 0.48 | 33.25% |
| Q2 2022 Q2Q % growth | 0.00 100.00% | -0.78 | 0.78 | 100.00% |
| Q1 2022 Q2Q % growth | -1.20 41.18% | -1.74 | 0.54 | 31.20% |
| Q4 2021 Q2Q % growth | -2.16 35.71% | -1.79 | -0.37 | -20.87% |
| Q3 2021 Q2Q % growth | -2.16 25.00% | -1.62 | -0.54 | -33.19% |
| Q2 2021 Q2Q % growth | -2.16 33.33% | -1.93 | -0.23 | -12.04% |
| Q1 2021 Q2Q % growth | -2.04 5.56% | -2.72 | 0.68 | 25.09% |
| Q4 2020 Q2Q % growth | -3.36 -33.33% | -1.54 | -1.82 | -117.86% |
| Q3 2020 Q2Q % growth | -2.88 -20.00% | -2.08 | -0.80 | -38.41% |
| Q2 2020 Q2Q % growth | -3.24 6.90% | -1.86 | -1.38 | -74.15% |
| Q1 2020 Q2Q % growth | -2.16 33.33% | -3.61 | 1.45 | 40.18% |
| Q4 2019 Q2Q % growth | -2.52 | -2.23 | -0.29 | -13.12% |
| Q3 2019 Q2Q % growth | -2.40 | -2.53 | 0.13 | 5.12% |
| Q2 2019 Q2Q % growth | -3.48 | -2.41 | -1.07 | -44.56% |
| Q1 2019 Q2Q % growth | -3.24 | -3.67 | 0.43 | 11.76% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -21K -195.45% | 192.443K | -213.443K | -110.91% |
| Q1 2025 Q2Q % growth | 25.43K 182.56% | 306K | -280.57K | -91.69% |
| Q4 2024 Q2Q % growth | -64K -103.54% | 1.36M | -1.424M | -104.71% |
| Q3 2024 Q2Q % growth | 41.7K -100.00% | 4.127M | -4.127M | -100.00% |
| Q2 2024 Q2Q % growth | 22K | 8.013M | -7.991M | -99.73% |
| Q1 2024 Q2Q % growth | 9K | 265.71K | -256.71K | -96.61% |
| Q4 2023 Q2Q % growth | 1.808M | 1.875M | -67K | -3.57% |
| Q3 2023 Q2Q % growth | 1M | 440.028K | 559.972K | 127.26% |
| Q2 2023 Q2Q % growth | -100.00% | 747.997K | -747.997K | -100.00% |
| Q1 2023 Q2Q % growth | 1.7M | -1.7M | -100.00% | |
| Q3 2022 Q2Q % growth | 2.03M | -2.03M | -100.00% | |
| Q2 2022 Q2Q % growth | 10M | 10.2M | -200K | -1.96% |
| Q1 2022 Q2Q % growth | 370.005K | -370.005K | -100.00% | |
| Q4 2021 Q2Q % growth | 1.275M | -1.275M | -100.00% | |
| Q3 2021 Q2Q % growth | 2.92M | -2.92M | -100.00% | |
| Q4 2020 Q2Q % growth | 530.4K | -530.4K | -100.00% | |
| Q3 2020 Q2Q % growth | 186.252K | -186.252K | -100.00% | |
| Q2 2020 Q2Q % growth | 212.415K | -212.415K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -8.07% | 21.91% | 23.52% |
| Revenue | 0% | -33.33% | -90.7% | -93.03% |